Susan Gasser to head Friedrich Miescher Institute

February 05, 2004 02:30 ET | Source: Novartis Pharma AG Novartis Pharma AG

Basel, 5 February 2004 - Susan Gasser, Professor for Molecular Biology at the University of Geneva, has been named the new director of the Friedrich Miescher Institute (FMI) in Basel.

Founded in 1970, the FMI is devoted to fundamental biomedical research and focuses on epigenetics, growth control and neurobiology.

Please see full press release under the following link:

Attachments

Novartis Release...

Recommended Reading

September 04, 2026 16:30 ET | Source: Novartis Pharma AG

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

Ad hoc announcement pursuant to Art. 53 LR Basel, September 4, 2026 – Novartis today announced that the pelacarsen phase III Lp(a)HORIZON trial, a pioneering cardiovascular outcomes study, did not...
Read More
September 01, 2026 01:15 ET | Source: Novartis Pharma AG

Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials

Ad hoc announcement pursuant to Art. 53 LR REMODEL-1/-2 trials met their primary endpoint, significantly reducing annualized relapse rate (ARR) vs teriflunomide in people living with relapsing...
Read More